Sign up Australia
Proactive Investors - Run By Investors For Investors

WeedMD partners with world-renowned Technion-Israel Institute of Technology for cannabis research project

Technion is widely recognized as one of the global leaders in medical cannabis research
cannabis leaves
The project will research the profiles of 25 of WeedMD’s cannabis strains

Canadian marijuana producer and distributor WeedMD Inc (CVE:WMD) has joined the world-renowned Cannabis Database Project led by the Technion-Israel Institute of Technology.

Those in the project will be collaborating in the research of cannabinoid and terpenoid profiles of 25 of WeedMD’s cannabis strains.

READ: WeedMD now selling medical cannabis oil

This data will then be added to an international database that correlates the pharmacological effects of the different strains.

From there, the most effective cannabis treatments - strains, dose and route of administration - for clinical purposes can be determined.

This is the first of several research and development initiatives WeedMD is working on as the firm develops its medical cannabis for both the domestic and global markets.

“We are proud to be at the forefront of investing in cannabis research, awareness and education,” said chief scientific officer Luc Duchesne.

“There are hundreds of cannabis strains available to medical patients, but each of these strains has a unique chemical profile, as well potentially unique medical properties.

“A significant barrier to the standardization of medical cannabis is identifying strains that are effective in the treatment of specific medical conditions and Technion is making ground-breaking discoveries to this effect.”

WeedMD shares rose 3.7% to C$2.26 on Wednesday morning.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Related Articles

Kaneh Bosom Biotechnology: experienced management, access to capital and a clear strategy paves the
The company says access to capital and a clear strategy will help it succeed

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use